Slovenia vs Türkiye: Hepatitis B surface antigen (HBsAg) prevalence
Slovenia
0.0%
in 2024
Türkiye
0.0%
in 2024
Slovenia rank
132nd
Türkiye rank
132nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Slovenia
- Türkiye
How they compare
Slovenia currently reports 0.0% against 0.0% in Türkiye, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Slovenia ahead.
Slovenia ranks 132nd and Türkiye ranks 132nd of 194 countries.
Slovenia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Slovenia | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.1% | 0.1% | Slovenia |
| 2020s | 0.1% | 0.1% | 0.0% | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Slovenia or Türkiye?
- Slovenia, at 0.0% against 0.0% in Türkiye as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Slovenia and Türkiye?
- 0.0%, with Slovenia ahead.
- How many years of comparable data are there for Slovenia and Türkiye?
- 10 years are reported by both, from 2015 to 2024.
- How do Slovenia and Türkiye rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Slovenia ranks 132nd and Türkiye ranks 132nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.